Latest DEF 14A proxy statements
AMEX
Ur-Energy Inc. has issued its proxy statement for the 2026 Annual and Special Meeting of Shareholders to be held on June 4, 2026.
NASDAQ
Axsome Therapeutics has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.
NASDAQ
Aquestive Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.
NASDAQ
Focus Universal Inc. seeks shareholder approval for a $250 million capital raise and a new digital asset treasury strategy at its 2026 Annual Meeting.
NASDAQ
MultiSensor AI Holdings, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and a proposed incentive plan amendment.
Presurance Holdings, Inc. announces its 2026 Annual Meeting of Shareholders to be held virtually on June 3, 2026.
NASDAQ
HF Foods Group Inc. releases its 2026 proxy statement detailing executive compensation, director elections, and strategic operational progress.
NYSE
Universal Insurance Holdings, Inc. has released its 2026 Proxy Statement detailing director elections, executive compensation, and auditor ratification.
NASDAQ
Karat Packaging Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation votes.
NYSE
DigitalOcean Holdings, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation disclosures.
NASDAQ
CRON
Cronos Group INCCronos Group Inc. has scheduled its 2026 Annual Meeting of Shareholders for June 18, 2026, to be held in a virtual-only format.
NASDAQ
Tectonic Therapeutic, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 8, 2026, to address director elections, auditor ratification, and executive compensation.
NYSE
OEC
Orion SAOrion S.A. has issued its 2026 proxy statement detailing the agenda for the upcoming Annual General Meeting of Shareholders scheduled for June 25, 2026.
NASDAQ
NDAQ
Nasdaq, INCNasdaq's 2026 proxy statement highlights record 2025 financial performance, successful Adenza integration, and an AI-first strategic roadmap.
NASDAQ
GPRE
Green Plains INCGreen Plains Inc. filed its 2026 Proxy Statement detailing director elections, executive compensation, and a proposal to increase shares available under its 2019 Equity Incentive Plan.
NASDAQ
AMPL
Amplitude, INCAmplitude, Inc. has filed its 2026 proxy statement detailing the upcoming annual meeting of stockholders scheduled for June 9, 2026.
NYSE
Centrus Energy Corp. reports robust 2025 financial and operational performance, including significant HALEU production and a large LEU backlog, while seeking shareholder approval for director elections, executive compensation, officer exculpation, and an amended Section 382 Rights Agreement.
NYSE
McEwen Inc. announces its 2026 Annual Meeting of Shareholders to be held on June 4, 2026, to vote on director elections, auditor ratification, and share issuance to Robert McEwen.
NASDAQ
AMSF
Amerisafe INCAMERISAFE, Inc. has filed its 2026 proxy statement detailing director elections, executive compensation, and proposed amendments to its Certificate of Formation.
NASDAQ
Adaptive Biotechnologies Corporation announces its 2026 Annual Meeting of Shareholders to be held virtually on June 5, 2026.
NYSE
Zeta Global Holdings Corp. announces its 2026 Annual Meeting of Stockholders to be held on June 16, 2026, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
CGON
Cg Oncology, INCCG Oncology, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 4, 2026.
NYSE
Ingersoll Rand Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 11, 2026.
NASDAQ
Maravai LifeSciences announces its 2026 Annual Meeting of Shareholders to be held virtually on May 26, 2026.
NASDAQ
Willdan Group, a professional services company, announced record financial results for fiscal year 2025 and outlined proposals for its 2026 Annual Meeting, including an increase in its performance incentive plan shares.
ALVR
Allovir, INCKalaris Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 3, 2026.
NASDAQ
BridgeBio Pharma, Inc. has filed its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation proposals.
NYSE
ZipRecruiter, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 9, 2026.
NYSE
Infinity Natural Resources, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 9, 2026.
NASDAQ
SVRA
Savara INCSavara Inc. seeks stockholder approval for a share authorization increase and amendments to its 2024 Omnibus Incentive Plan ahead of potential commercialization.